cirpublications.com-iIQo-1790880684-n496222888 1790880684 Clinical Intelligence Research Press info@cirpublications.com Clinical Intelligence Research Press Journal of Artificial Intelligence for Healthcare Systems J. Artif. Intell. Healthc. Syst. 3149-8981 2024 3 1 Maria Silva Joao Pereira 2024 10.68159/n496222888 https://cirpublications.com/pub/journal/1/article/n496222888 Coudray N, Ocampo PS, Sakellaropoulos T, Narula N, Snuderl M, Fenyö D, et al. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med. 2018;24(10):1559-67. 10.1038/s41591-018-0177-5 Lu MY, Williamson DFK, Chen TY, Chen RJ, Barbieri M, Mahmood F, et al. Data-efficient and weakly supervised computational pathology on whole-slide images. Nat Biomed Eng. 2021;5(6):555-70. 10.1038/s41551-021-00682-w Wiesweg M, Mairinger F, Reis H, Goetz M, Kollmeier J, Misch D, et al. Machine learning reveals a PD-L1-independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context. Eur J Cancer. 2020;140:76-85. 10.1016/j.ejca.2020.08.021 Niu Y, Wang L, Zhang X, Han Y, Yang C, Wang M, et al. Predicting tumor mutational burden from lung adenocarcinoma histopathological images using deep learning. Front Oncol. 2022;12:927426. 10.3389/fonc.2022.927426 Dammak S, Cecchini MJ, Breadner D, Ward AD. Using deep learning to predict tumor mutational burden from scans of H&E-stained multicenter slides of lung squamous cell carcinoma. J Med Imaging (Bellingham). 2023;10(1):017502. 10.1117/1.JMI.10.1.017502 Chen RJ, Lu MY, Wang J, Williamson DFK, Rodig SJ, Lindeman NI, et al. Pathomic fusion: an integrated framework for fusing histopathology and genomic features for cancer diagnosis and prognosis. IEEE Trans Med Imaging. 2022;41(4):757-70. 10.1109/TMI.2020.3021387 Li B, Yang L, Zhang H, Li H, Jiang C, Zhang Y, et al. Outcome-supervised deep learning on pathologic whole slide images for survival prediction of immunotherapy in patients with non-small cell lung cancer. Mod Pathol. 2023;36(8):100208. 10.1016/j.modpat.2023.100208 Park S, Ock CY, Kim H, Pereira S, Park S, Ma M, et al. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as complementary biomarker for immune checkpoint inhibition in non-small-cell lung cancer. J Clin Oncol. 2022;40(17):1916-28. 10.1200/JCO.21.02010 Tian P, He B, Mu W, Liu K, Liu L, Zhan Y, et al. Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images. Theranostics. 2021;11(5):2098-107. 10.7150/thno.52286 Rakaee M, Adib E, Ricciuti B, Sholl LM, Shi W, Alchahin A, et al. Association of machine learning-based assessment of tumor-infiltrating lymphocytes on standard histologic images with outcomes of immunotherapy in patients with NSCLC. JAMA Oncol. 2023;9(1):51-60. 10.1001/jamaoncol.2022.4452 Yang Y, Yang J, Shen L, Chen J, Xia L, Luo Q, et al. A multi-omics-based serial deep learning approach to predict clinical outcomes of single-agent anti-PD-1/PD-L1 immunotherapy in advanced stage non-small-cell lung cancer. Am J Transl Res. 2021;13(2):743-56. Kong J, Ha D, Lee J, Kim I, Park M, Im SH, et al. Network-based machine learning approach to predict immunotherapy response in cancer patients. Nat Commun. 2022;13(1):3703. 10.1038/s41467-022-31405-6 Lipkova J, Chen RJ, Chen B, Lu MY, Barbieri M, Shao D, et al. Artificial intelligence for multimodal data integration in oncology. Cancer Cell. 2022;40(10):1095-110. 10.1016/j.ccell.2022.09.012 Steyaert S, Pizurica M, Nagaraj D, Khandelwal P, Hernandez-Boussard T, Gevaert O, et al. Multimodal data fusion for cancer biomarker discovery with deep learning. Nat Mach Intell. 2023;5(4):351-62. 10.1038/s42256-023-00633-5 Chen RJ, Lu MY, Weng WH, Chen TY, Williamson DFK, Manz T, et al. Multimodal co-attention transformer for survival prediction in gigapixel whole slide images. In: Proc IEEE/CVF Int Conf Comput Vis (ICCV). 2021. p. 4015-25. 10.1109/ICCV48922.2021.00401 Shamai G, Livne A, Polónia A, Sabo E, Cretu A, Peleg R, et al. Deep learning-based image analysis predicts PD-L1 status from H&E-stained histopathology images in breast cancer. Nat Commun. 2022;13(1):6753. 10.1038/s41467-022-34435-4 Liu Q, Yao J, Yao L, Chen X, Zhou J, Xiao G, et al. M2 fusion: Bayesian-based multimodal multi-level fusion on colorectal cancer microsatellite instability prediction. In: Int Conf Med Image Comput Comput Assist Interv (MICCAI). Cham: Springer; 2023. p. 125-34. 10.1007/978-3-031-43907-0_13 Schneider L, Wies C, Krieghoff-Henning EI, Bucher TC, Utikal JS, Schadendorf D, et al. Multimodal integration of image, epigenetic and clinical data to predict BRAF mutation status in melanoma. Eur J Cancer. 2023;183:131-8. 10.1016/j.ejca.2023.02.018 Xie X, Wang X, Liang Y, Yang J, Wu Y, Zhang T, et al. Evaluating cancer-related biomarkers based on pathological images: a systematic review. Front Oncol. 2021;11:763527. 10.3389/fonc.2021.763527 Wang C, Ma J, Shao J, Zhang S, Liu Z, Sun H, et al. Predicting EGFR and PD-L1 status in NSCLC patients using multitask AI system based on CT images. Front Immunol. 2022;13:813072. 10.3389/fimmu.2022.813072 Saad MB, Hong L, Aminu M, Vokes NI, Chen P, Elhalawani H, et al. Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study. Lancet Digit Health. 2023;5(7):e404-e420. 10.1016/S2589-7500(23)00087-0 Sadhwani A, Chang HW, Behrooz A, Brown T, Auvigne-Flament I, Patel P, et al. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images. Sci Rep. 2021;11(1):16605. 10.1038/s41598-021-95886-4 Cheng G, Zhang F, Xing Y, Hu X, Zhang H, Sun K, et al. Artificial intelligence-assisted score analysis for predicting the expression of the immunotherapy biomarker PD-L1 in lung cancer. Front Immunol. 2022;13:893198. 10.3389/fimmu.2022.893198 Lin H, Pan X, Feng Z, Yan L, Hua J, Shao C, et al. Automated whole-slide images assessment of immune infiltration in resected non-small-cell lung cancer: towards better risk-stratification. J Transl Med. 2022;20(1):261. 10.1186/s12967-022-03441-5 Meng X, Liu Y, Zhang J, Teng F, Xing L, Yu J. PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: new development and challenges. Cancer Lett. 2017;405:29-37. 10.1016/j.canlet.2017.06.033 Tan WC, Nerurkar SN, Cai HY, Ng HH, Wu D, Wee YTF, et al. Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy. Cancer Commun (Lond). 2020;40(4):135-53. 10.1002/cac2.12023 Wang S, Yang DM, Rong R, Zhan X, Fujimoto J, Liu H, et al. Artificial intelligence in lung cancer pathology image analysis. Cancers (Basel). 2019;11(11):1673. 10.3390/cancers11111673 Liu J, Islam MT, Sang S, Qiu L, Xing L. Biology-aware mutation-based deep learning for outcome prediction of cancer immunotherapy with immune checkpoint inhibitors. NPJ Precis Oncol. 2023;7(1):117. 10.1038/s41698-023-00471-1 Gao Q, Yang L, Lu M, Jin R, Ye H, Wang X, et al. The artificial intelligence and machine learning in lung cancer immunotherapy. J Hematol Oncol. 2023;16(1):55. 10.1186/s13045-023-01452-7